Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran

Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran – Authors' Reply Publisher Pubmed

Darvishian M¹ ; Sharafkhah M² ; Poustchi H² ; Malekzadeh R^{3, 4}

Show Affiliations

1. Cancer Control Research, BC Cancer Research Centre, Vancouver, BC, Canada
2. Liver and Pancreatobiliary Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, 14117â€“13135, Iran
3. Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, 14117â€“13135, Iran
4. Digestive Disease Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, 14117â€“13135, Iran

Source: The Lancet Infectious Diseases Published:2021

Abstract

[No abstract available]

Related Docs

1. Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran, The Lancet Infectious Diseases (2021)

Experts (# of related papers)

Mohammad Ali Mansournia (1)

Style	Citing Format
MLA	Darvishian M, et al.. "Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran – Authors' Reply." The Lancet Infectious Diseases, vol. 21, no. 5, 2021, pp. 604-605.
APA	Darvishian M, Sharafkhah M, Poustchi H, Malekzadeh R (2021). Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran – Authors' Reply. The Lancet Infectious Diseases, 21(5), 604-605.
Chicago	Darvishian M, Sharafkhah M, Poustchi H, Malekzadeh R. "Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran – Authors' Reply." The Lancet Infectious Diseases 21, no. 5 (2021): 604-605.
Harvard	Darvishian M et al. (2021) 'Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran – Authors' Reply', The Lancet Infectious Diseases, 21(5), pp. 604-605.
Vancouver	Darvishian M, Sharafkhah M, Poustchi H, Malekzadeh R. Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran – Authors' Reply. The Lancet Infectious Diseases. 2021;21(5):604-605.
BibTex	@article{ author = {Darvishian M and Sharafkhah M and Poustchi H and Malekzadeh R}, title = {Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran – Authors' Reply}, journal = {The Lancet Infectious Diseases}, volume = {21}, number = {5}, pages = {604-605}, year = {2021} }
RIS	TY - JOUR AU - Darvishian M AU - Sharafkhah M AU - Poustchi H AU - Malekzadeh R TI - Estimates of Anti-Sars-Cov-2 Antibody Seroprevalence in Iran – Authors' Reply JO - The Lancet Infectious Diseases VL - 21 IS - 5 SP - 604 EP - 605 PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract